SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-24-017997
Filing Date
2024-06-24
Accepted
2024-06-24 16:37:14
Documents
1
Period of Report
2024-03-14

Document Format Files

Seq Description Document Type Size
1 form3a-06242024_080610.html 3/A  
1 form3a-06242024_080610.xml 3/A 2618
  Complete submission text file 0001415889-24-017997.txt   4123
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005
Business Address
Chong Ngai Hang Victor (Reporting) CIK: 0002014921 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-37783 | Film No.: 241064901